Breaking News Instant updates and real-time market news.

BLUE

bluebird bio

$65.24

-0.31 (-0.47%)

07:42
10/14/16
10/14
07:42
10/14/16
07:42

bluebird bio price target raised to $80 from $67 at Leerink

Leerink analyst Michael Schmidt raised his price target for bluebird bio to $80 from $67 as he sees the clinical development and regulatory path for the company's pipeline products incrementally more de-risked. While development of key product LentiGlobin in transfusion-dependent beta-thalassemia and severe sickle cell disease has been more complex than initially anticipated, the analyst believes bluebird bio is well positioned to overcome remaining technical hurdles. He reiterates an Outperform rating on the shares.

  • 06

    Nov

  • 29

    Nov

BLUE bluebird bio
$65.24

-0.31 (-0.47%)

09/22/16
09/22/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: Packaging Corp. (PKG) initiated with a Sell at Goldman. 2. Netlist (NLST) initiated with a Buy at B. Riley. 3. Weyerhaeuser (WY) initiated with a Conviction Buy at Goldman. 4. bluebird bio (BLUE) reinstated with a Buy at Roth Capital. 5. Dentsply Sirona (XRAY) initiated with a Neutral at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
10/07/16
GSCO
10/07/16
NO CHANGE
GSCO
Smid-cap Biotech sector upgraded to Attractive from Neutral at Goldman
Goldman analyst Salveen Richter upgraded the Smid-cap biotechnology to Attractive and said he favors and companies with near-term pipeline data or regulatory events where he has conviction.Names he recommends are Buy rated BioMarin (BMRN), bluebird bio (BLUE), GW Pharma (GWPH), Incyte (INCY), Kite (KITE), and Sage (SAGE).
10/14/16
CANT
10/14/16
DOWNGRADE
CANT
Sell
bluebird bio downgraded to Sell from Hold at Cantor
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell and cut his price target for the shares to $37 from $42.
10/14/16
CANT
10/14/16
DOWNGRADE
Target $37
CANT
Sell
Cantor cuts bluebird bio to Sell with $37 price target
Cantor Fitzgerald analyst Elemer Piros downgraded bluebird bio to Sell from Hold and dropped his price target for the shares to $37 from $42. The biotech focused on developing gene therapies closed yesterday down 31c to $64.24. The analyst sees a lack of catalysts as he does not expect data to be announced at this year's American Society of Hematology conference to de-risk the hemoglobinopathy programs. Bluebird disclosed yesterday that all future LentiGlobin trials going forward will use its improved manufacturing process, and those trials are just beginning, Piros tells investors in a research note. As such, initial data on improved transduction efficiency may not become available until 2018, the analyst contends. With this year's ASH meeting not a catalyst, Piros expects selling pressure on bluebird shares.

TODAY'S FREE FLY STORIES

BIDU

Baidu

$187.86

1.19 (0.64%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Baidu CFO Jennifer Li to step down »

Baidu also announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

URBN

Urban Outfitters

$23.15

-0.55 (-2.32%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Urban Outfitters announces changes to store leadership »

Urban Outfitters, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INT

World Fuel Services

$36.79

-0.31 (-0.84%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
World Fuel Services reports Q1 adjusted EPS 64c, consensus 49c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Hot Stocks
Inter Parfums says doesn't expect Q1-type growth in remaining quarter »

""First quarter…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOBL

MobileIron

$4.45

-0.05 (-1.11%)

16:34
04/27/17
04/27
16:34
04/27/17
16:34
Earnings
MobileIron reports Q1 non-GAAP EPS (6c), consensus (8c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 08

    Jun

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:33
04/27/17
04/27
16:33
04/27/17
16:33
Earnings
Inter Parfums backs FY17 EPS $1.20-$1.24, consensus $1.25 »

Backs FY17 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MERC

Mercer

$12.55

0.1 (0.80%)

16:33
04/27/17
04/27
16:33
04/27/17
16:33
Earnings
Mercer reports Q1 EPS 15c, consensus 28c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Apr

SGMS

Scientific Games

$22.80

-0.1 (-0.44%)

16:33
04/27/17
04/27
16:33
04/27/17
16:33
Earnings
Scientific Games reports Q1 EPS ($1.14), consensus (72c) »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 30

    May

VDSI

VASCO Data Security

$13.60

-0.05 (-0.37%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
Breaking Earnings news story on VASCO Data Security »

VASCO Data Security sees…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

IPAR

Inter Parfums

$36.95

0.2 (0.54%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
Inter Parfums reports Q1 revenue $143.1M, consensus $120.19M. »

"The 57% increase in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VDSI

VASCO Data Security

$13.60

-0.05 (-0.37%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
VASCO Data Security reports Q1 non-GAAP EPS 8c, consensus (3c) »

Reports Q1 revenue $42M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

LRN

K12

$20.26

-0.17 (-0.83%)

16:32
04/27/17
04/27
16:32
04/27/17
16:32
Earnings
K12 sees Q4 revenue $215M-$220M, consensus $223.96M »

Sees Q4 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

EHTH

eHealth

$11.74

0.23 (2.00%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
Breaking Earnings news story on eHealth »

eHealth sees FY17 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 10

    May

  • 30

    May

  • 06

    Jun

BIDU

Baidu

$187.86

1.19 (0.64%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
Baidu sees Q2 revenue $2.974B-$3.048B, consensus $3.03B »

Representing an annual…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

LRN

K12

$20.26

-0.17 (-0.83%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
K12 reports Q3 EPS 23c, consensus 25c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Options
Preliminary option volume of 15.6M today »

Preliminary option volume…

EHTH

eHealth

$11.74

0.23 (2.00%)

16:31
04/27/17
04/27
16:31
04/27/17
16:31
Earnings
eHealth sees FY17 revenue $165M-$175M, consensus $169.3M »

Sees FY17 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 10

    May

  • 30

    May

  • 06

    Jun

TRMB

Trimble

$32.62

0.28 (0.87%)

16:30
04/27/17
04/27
16:30
04/27/17
16:30
Earnings
Trimble sees Q2 non-GAAP EPS 33c-38c, consensus 34c »

Sees Q2 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

VSAR

Versartis

$19.80

-0.1 (-0.50%)

16:30
04/27/17
04/27
16:30
04/27/17
16:30
Earnings
Breaking Earnings news story on Versartis »

Versartis reports Q1 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BIDU

Baidu

$187.86

1.19 (0.64%)

16:30
04/27/17
04/27
16:30
04/27/17
16:30
Earnings
Baidu reports Q1 adjusted EPS $1.00, consensus 86c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

TRMB

Trimble

$32.62

0.28 (0.87%)

16:30
04/27/17
04/27
16:30
04/27/17
16:30
Earnings
Trimble reports Q1 non-GAAP EPS 33c, consensus 30c »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

PFG

Principal Financial

$65.18

0.87 (1.35%)

16:30
04/27/17
04/27
16:30
04/27/17
16:30
Earnings
Principal Financial reports Q1 ops EPS $1.27, consensus $1.21 »

Reports Q1 assets under…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 28

    Apr

  • 16

    May

KTEC

Key Technology

$12.54

-0.54 (-4.13%)

16:29
04/27/17
04/27
16:29
04/27/17
16:29
Hot Stocks
Key Technology wins $9M deal with Lutosa »

Key Technology has been…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

COLM

Columbia Sportswear

$59.77

0.34 (0.57%)

16:29
04/27/17
04/27
16:29
04/27/17
16:29
Earnings
Columbia Sportswear cuts FY17 operating income to up 3% to $256M-$265M »

Previously forecast…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

MSCC

Microsemi

$49.14

0.15 (0.31%)

16:29
04/27/17
04/27
16:29
04/27/17
16:29
Earnings
Microsemi sees Q3 non-GAAP EPS 94c-$1.04, consensus 97c »

Sees Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Apr

  • 09

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.